150 related articles for article (PubMed ID: 36686752)
21. Effectiveness of Postoperative Radiotherapy on Atypical Meningioma Patients: A Population-Based Study.
Zeng Q; Shi F; Guo Z
Front Oncol; 2019; 9():34. PubMed ID: 30805304
[No Abstract] [Full Text] [Related]
22. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
Zinn PO; Colen RR; Kasper EM; Burkhardt JK
Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
[TBL] [Abstract][Full Text] [Related]
23. Clinical Features, Treatment, and Long-term Outcomes of Central Neurocytoma: A 20-Year Experience at a Single Center.
Wang M; Zhou P; Zhang S; Liu X; Lv L; Wang Z; Ye F; Wang X; Jiang S
World Neurosurg; 2018 Jan; 109():e59-e66. PubMed ID: 28958923
[TBL] [Abstract][Full Text] [Related]
24. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
25. The implication of giant tumor size on surgical resection, oncological, and functional outcomes in craniopharyngioma.
Sadhasivam S; Menon G; Abraham M; Nair SN
Pituitary; 2020 Oct; 23(5):515-525. PubMed ID: 32451987
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
Imber BS; Braunstein SE; Wu FY; Nabavizadeh N; Boehling N; Weinberg VK; Tihan T; Barnes M; Mueller S; Butowski NA; Clarke JL; Chang SM; McDermott MM; Prados MD; Berger MS; Haas-Kogan DA
J Neurooncol; 2016 Jan; 126(1):193-200. PubMed ID: 26493740
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.
Oh MC; Ivan ME; Sun MZ; Kaur G; Safaee M; Kim JM; Sayegh ET; Aranda D; Parsa AT
Neuro Oncol; 2013 Feb; 15(2):208-15. PubMed ID: 23229996
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study.
Chu Y; Xu B; Song Q; Hu Q
Clin Transl Oncol; 2021 Jan; 23(1):164-171. PubMed ID: 32488805
[TBL] [Abstract][Full Text] [Related]
29. Central Neurocytoma Treatment Modalities: A Systematic Review Assessing the Outcomes of Combined Maximal Safe Resection and Radiotherapy with Gross Total Resection.
Mahavadi AK; Patel PM; Kuchakulla M; Shah AH; Eichberg D; Luther EM; Komotar RJ; Ivan ME
World Neurosurg; 2020 May; 137():e176-e182. PubMed ID: 32001392
[TBL] [Abstract][Full Text] [Related]
30. Atypical Central Neurocytoma: An Investigation of Prognostic Factors.
AbdelBari Mattar M; Shebl AM; Toson EA
World Neurosurg; 2021 Feb; 146():e184-e193. PubMed ID: 33091649
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and survival in low grade gliomas of the spinal cord: A population-based analysis from 2006 to 2012.
Diaz-Aguilar D; ReFaey K; Clifton W; Durcanova B; Chen SG; Deen HG; Bydon M; Trifiletti DM; Pichelmann MA; Quiñones-Hinojosa A
J Clin Neurosci; 2019 Mar; 61():14-21. PubMed ID: 30528541
[TBL] [Abstract][Full Text] [Related]
32. Advantages of gross total resection in patients with astrocytoma: A population-based study.
Mao H; Li X; Mao W
Oncol Lett; 2020 Jun; 19(6):3761-3774. PubMed ID: 32391094
[TBL] [Abstract][Full Text] [Related]
33. Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.
Kinslow CJ; Bruce SS; Rae AI; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sonabend AM; Wang TJC
J Neurooncol; 2018 May; 138(1):173-182. PubMed ID: 29427152
[TBL] [Abstract][Full Text] [Related]
34. Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database.
Jiang W; Shou J; Shi H; Wen L; Zhang H; Zheng S; Li C; Ma J
Technol Cancer Res Treat; 2021; 20():15330338211019507. PubMed ID: 34032149
[TBL] [Abstract][Full Text] [Related]
35. Central neurocytomas.
Schild SE; Scheithauer BW; Haddock MG; Schiff D; Burger PC; Wong WW; Lyons MK
Cancer; 1997 Feb; 79(4):790-5. PubMed ID: 9024717
[TBL] [Abstract][Full Text] [Related]
36. Primary Malignant Melanoma of the Brain: A Population-Based Study.
Puyana C; Denyer S; Burch T; Bhimani AD; McGuire LS; Patel AS; Mehta AI
World Neurosurg; 2019 Oct; 130():e1091-e1097. PubMed ID: 31323401
[TBL] [Abstract][Full Text] [Related]
37. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.
Thumallapally N; Meshref A; Mousa M; Terjanian T
BMC Cancer; 2017 Jan; 17(1):13. PubMed ID: 28056880
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Factors and Treatment of Spinal Astrocytomas: A Multi-institutional Cohort Analysis.
Zou Y; Sun J; Zhou Y; Bai HX; Huang X; Babu R; Landi A; Foong KS; Zhang Z; Woo JH; Tao Y; Li X; Tang X; Xiao B; Zhang PJ; Yang L
Spine (Phila Pa 1976); 2018 May; 43(10):E565-E573. PubMed ID: 29135884
[TBL] [Abstract][Full Text] [Related]
39. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
[TBL] [Abstract][Full Text] [Related]
40. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.
Ma XJ; Li D; Wang L; Hao SY; Zhang LW; Zhang JT; Wu Z
Neurosurg Rev; 2020 Feb; 43(1):281-292. PubMed ID: 30535934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
